JP2006523685A - 循環器疾患の治療のためのｌ−カルニチンの使用 - Google Patents

循環器疾患の治療のためのｌ−カルニチンの使用 Download PDF

Info

Publication number
JP2006523685A
JP2006523685A JP2006507635A JP2006507635A JP2006523685A JP 2006523685 A JP2006523685 A JP 2006523685A JP 2006507635 A JP2006507635 A JP 2006507635A JP 2006507635 A JP2006507635 A JP 2006507635A JP 2006523685 A JP2006523685 A JP 2006523685A
Authority
JP
Japan
Prior art keywords
carnitine
use according
acid
myocardial infarction
acute myocardial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006507635A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006523685A5 (enExample
Inventor
アレアルド・コヴェレック
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of JP2006523685A publication Critical patent/JP2006523685A/ja
Publication of JP2006523685A5 publication Critical patent/JP2006523685A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2006507635A 2003-04-17 2004-03-03 循環器疾患の治療のためのｌ−カルニチンの使用 Pending JP2006523685A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000178A ITRM20030178A1 (it) 2003-04-17 2003-04-17 Uso della l-carnitina per il trattamento di patologie cardiovascolari.
PCT/IT2004/000107 WO2004091602A1 (en) 2003-04-17 2004-03-03 Use of l-carnitine for the treatment of cardiovascular diseases

Publications (2)

Publication Number Publication Date
JP2006523685A true JP2006523685A (ja) 2006-10-19
JP2006523685A5 JP2006523685A5 (enExample) 2007-05-10

Family

ID=29765768

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006507635A Pending JP2006523685A (ja) 2003-04-17 2004-03-03 循環器疾患の治療のためのｌ−カルニチンの使用

Country Status (11)

Country Link
US (1) US20060052450A1 (enExample)
EP (1) EP1613301A1 (enExample)
JP (1) JP2006523685A (enExample)
KR (1) KR20050121196A (enExample)
CN (2) CN101467992A (enExample)
AU (2) AU2004229256A1 (enExample)
BR (1) BRPI0406552A (enExample)
CA (1) CA2508636A1 (enExample)
IT (1) ITRM20030178A1 (enExample)
MX (1) MXPA05007612A (enExample)
WO (1) WO2004091602A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011515471A (ja) * 2008-03-26 2011-05-19 オーソロジック コーポレイション 急性心筋梗塞を処置するための方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040346A1 (it) * 2004-07-13 2004-10-13 Sigma Tau Ind Farmaceuti Uso della l-carnitina per il trattamento di patologie cardiovascolari.
US20070260674A1 (en) * 2006-05-02 2007-11-08 Research In Motion Limited Push framework for delivery of dynamic mobile content
EP2353596A1 (en) 2010-02-02 2011-08-10 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
WO2012150146A1 (en) 2011-05-03 2012-11-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Composition useful for the treatment of lipid metabolism disorders
CN114073705A (zh) * 2020-08-14 2022-02-22 常州高新技术产业开发区三维工业技术研究所有限公司 一种降尿酸药物组合物及其应用
CN112180013B (zh) * 2020-09-29 2022-11-15 上海脉示生物技术有限公司 用于心肌梗死诊断的肠道微生物代谢标志物组合物及其检测方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS531812B2 (enExample) * 1972-12-07 1978-01-23
WO2000030637A1 (en) * 1998-11-26 2000-06-02 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of fumarate salt of l-carnitine or its alkanoyl derivatives in ischaemia

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6010036847, Ｔｈｅ Ｊｏｕｒｎａｌ ｏｆ ｔｈｅ Ａｍｅｒｉｃａｎ Ｃｏｌｌｅｇｅ ｏｆ Ｃａｒｄｉｏｌｏｇｙ, 1995, ２６（２）, ｐｐ．３８０−３８７ *
JPN6010036848, Ｐｏｓｔｇｒａｄｕａｔｅ Ｍｅｄｉｃｉｎｅ Ｊｏｕｒｎａｌ, 1996, ７２, ｐｐ．４５−５０ *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011515471A (ja) * 2008-03-26 2011-05-19 オーソロジック コーポレイション 急性心筋梗塞を処置するための方法

Also Published As

Publication number Publication date
CA2508636A1 (en) 2004-10-28
EP1613301A1 (en) 2006-01-11
ITRM20030178A0 (it) 2003-04-17
AU2010202396A1 (en) 2010-07-01
KR20050121196A (ko) 2005-12-26
ITRM20030178A1 (it) 2004-10-18
MXPA05007612A (es) 2005-09-30
US20060052450A1 (en) 2006-03-09
AU2004229256A1 (en) 2004-10-28
CN1717232A (zh) 2006-01-04
WO2004091602A1 (en) 2004-10-28
BRPI0406552A (pt) 2005-12-20
CN101467992A (zh) 2009-07-01

Similar Documents

Publication Publication Date Title
AU2010202396A1 (en) Use of L-carnitine for the treatment of cardiovascular diseases
KR20090047424A (ko) 굴심방 결절 Ｉｆ 전류 억제제와 앤지오텐신 전환 효소 억제제의 회합체, 및 이를 함유한 약제 조성물
US5804204A (en) Potassium salts for treatment of hypertension
JP2006523685A5 (enExample)
US5498428A (en) Treatment of hypertension by oral administration of potassium bicarbonate
JP5230195B2 (ja) 心血管疾患の治療のためのｌ−カルニチンおよびグルコースの使用
HK1132174A (en) Use of l-carnitine for the treatment of cardiovascular diseases
US20090042983A1 (en) Use of L-carnitine for the treatment of cardiovascular diseases
HK1085929A (en) Use of l-carnitine for the treatment of cardiovascular diseases
HK1166003B (en) Use of l-carnitine and glucose for the treatment of cardiovascular diseases
HK1113542B (en) Use of l-carnitine and glucose for the treatment of cardiovascular diseases
EP1937245A1 (en) Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients
BRPI1000685A2 (pt) uso do clopidogrel com ácido acetilsalicìlico (asa) para a preparação de um medicamento para uso na prevenção de eventos vasculares maiores

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070301

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070301

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100706

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101006

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101014

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101108

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101130

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20140120